Hemispherx BioPharma Inc. (HEB) Surged 6.7% or 0.01 To Price $0.2 On Monday


Hemispherx BioPharma Inc. (HEB) surged 6.7% or 0.01 to $0.2. It is about 306122 shares traded, which is 98.47% compare to the average total volume 310886. The market cap of HEB is $9.51 million. The year to date change is -39.67%. The 52 week price range is from $0.15 to $0.65. Price of HEB have changed 2.78% during last week. It have changed -12.20% over last month, -27.88% over last 3 months, -41.82% over last 6 months and -43.94% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HEB is 0.21. It is 5.00% above current price. The 200-day Moving Averages for HEB is 0.31. It is 55.00% above current price. The 52-week High is 0.65. It is 225.00% from the current price. The 52-week Low is 0.15. It is -25.00% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of HEB is 1.41 on 2018-11-15. Short % to float is 1.01%. There are some statistics of HEB. It is has market cap $9.51 million. The share outstanding is 48.19 million. The average volume is 310886. The percent of top 15 Institution holding is 8.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HEB is -124.55%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HEB is -68.58%.


Tags:

Share this post